EURETINA Innovation Spotlight (EIS)
Wednesday 3 September 2025
Le Palais des Congrès, Paris
EIS Organising Committee
Prof. Anat Loewenstein
President
EURETINA
Dr. Kourous Rezaei
Co-opted Board Member
EURETINA
PROF. Martin Zinkernagel
General Secretary
EURETINA
Prof. Nicole Eter
PRESIDENT ELECT
EURETINA
Mr. Alistair Laidlaw
Past President
EURETINA
DARA CONLON
EXECUTIVE VICE-PRESIDENT
EURETINA
Contributors
Euretina is delighted to announce the following speakers and panellists confirmed to participate in the EURETINA Innovation Spotlight (EIS) taking place on the 3rd September 2025 at the Palais des Congrès in Paris, preceding the EURETINA Annual Congress.
Dimitris Aktypis
Senior Director, International Surgical Marketing
ALCON
Dr. Reza Abedian
Head of Business Development & Customer Solutions ‑ Devices Advanced Technologies
GERRESHEIMER
Muhammad Ali Memon
Chief Medical Officer
COMPLEMENT THERAPEUTICS
Yaniv Barkana, MD
Chief Medical Officer
GALIMEDIX THERAPEUTICS
Dr. Sam Barone
CMO
NANOSCOPE THERAPEUTICS
Prof. Francesco Bandello
University Vita-Salute Ospedale San Raffaele
ITALY
Prof. Bart Leroy
Ghent University Hospital
BELGIUM
Pierre Billardon
CEO, DORC / Head of Business Sectors Surgery Posterior Segment, ZEISS MEDICAL TECHNOLOGY
DORC / ZEISS MEDICAL TECHNOLOGY
Dr. Patrick Bussfeld
Head of Medical Affairs Pipeline Eye Health
BOEHRINGER INGELHEIM
Thomas Ciulla, MD, MBA, FASRS
Adjunct Clinical Professor of Ophthalmology
INDIANA UNIVERSITY SCHOOL OF MEDICINE
Dhaval Desai
Chief Development Officer
4D MOLECULAR THERAPEUTICS
Brad Doerschuk
PRESIDENT & CEO
INFOCUS CLINICAL RESEARCH
Kevin Douglas
Medical Director, Eye Care Retina
ABBVIE
Prof. Nicole Eter
PRESIDENT ELECT
EURETINA
Marco Ferroni, PhD
Chief Executive Officer & Co-Founder
MGSHELL
Peter Francis
CMO/CSO
RAY THERAPEUTICS
Ulrich Granzer
CEO
GRANZER REGULATORY CONSULTING & SERVICES
Anders Haegerstrand
CEO
ANNEXIN PHARMACEUTICALS
Prof. Frank Holz
University of Bonn
GERMANY
Ralf Hornig, PhD
Clinical Affairs Director
SCIENCE CORPORATION
Petri Huhtinen, PhD
Clinical Director
OPTOMED
Wesley Jackson
President & Chief Scientific Officer
VALITOR
Bob Jahr
President and CEO
OUTLOOK THERAPEUTICS
Scott Jones
Chief Commercial Officer
EYEPOINT PHARMACEUTICALS
Peter Kaiser, MD
Chief Development Officer
OCULAR THERAPEUTIX
Arshad Khanani
University of Nevada
USA
Prof. Caroline Klaver
Erasmus University Medical Center
THE NETHERLANDS
Sharon Klier, MD
Chief Development Officer
OCULIS
Mr. Alistair Laidlaw
Past President
EURETINA
Sergio Leal, MD
Vice President Ophthalmology Development Lead
BAYER
Luis Lesmes
CEO
ADAPTIVE SENSORY TECHNOLOGY
Prof. Anat Loewenstein
President
EURETINA
Stephanie Magazzeni
Chief Scientific Officer
HEIDELBERG ENGINEERING
Anne Marie Cairns
Chief Clinical Officer
OPTOS
Marina Mesquida, MD MSc PhD
Senior Medical Director, Pharma Research and Early Development
ROCHE
Natalia Misciattelli
CEO
AAVANTGARDE
Jane Moseley
Senior Scientific Officer
EUROPEAN MEDICINES AGENCY
Michael O'Rourke
CEO & Director
RE-VANA THERAPEUTICS
Lolita Petit
Chief Scientific Officer
COAVE THERAPEUTICS
Elisa Petris
Partner
SYNCONA INVESTMENT MANAGEMENT LIMITED
Dr. Kourous Rezaei
Co-opted Board Member
EURETINA
Grazia Pertile
Sacro Cuore Hospital
ITALY
Morgane Rousselot
President & CEO
SEABELIFE BIOTECH
Reza Safaei
SVP & Head Medical Affairs
APELLIS
Georgy Shakirin
Head of Artificial Intelligence
ZEISS MEDICAL TECHNOLOGY
Rich Small
CEO
NEUROTECH
Dr. Kali Stasi
Chief Medical Officer
SPARINGVISION
Patricia Udaondo
University of Valencia
SPAIN
Andrew Want, MBBS, PhD, FRCOphth
Global Medical Lead
ASTELLAS PHARMA INC.
Lejla Vajzovic, MD, FASRS
Scientific Advisory Board Member
OCUGEN
Sherri Van Everen
SVP – Ophthalmology Clinical Development
REGENXBIO
Michaël Vlemmix
Partner
LIFE SCIENCES GIMV
Dr. Charles Wykoff
Director of Research
RETINA CONSULTANTS OF TEXAS
Roger Zhang
Vice President
SAMSARA BIOCAPITAL
PROF. Martin Zinkernagel
General Secretary
EURETINA